Avaí Bio, Inc.
AVAI
$0.33
-$0.02-4.68%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.29M | 1.20M | 1.44M | 1.46M | 1.77M |
| Depreciation & Amortization | 35.30K | 48.30K | 61.30K | 74.30K | 105.80K |
| Other Operating Expenses | -323.20K | -343.80K | -402.20K | -390.70K | 34.90K |
| Total Operating Expenses | 1.03M | 928.80K | 1.10M | 1.14M | 1.91M |
| Operating Income | -1.03M | -928.80K | -1.10M | -1.14M | -1.91M |
| Income Before Tax | -1.03M | -928.80K | -1.10M | -1.14M | -1.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.03 | -0.93 | -1.10 | -1.14 | -1.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.03M | -928.80K | -1.10M | -1.14M | -1.91M |
| EBIT | -1.03M | -928.80K | -1.10M | -1.14M | -1.91M |
| EBITDA | -986.60K | -872.20K | -1.03M | -1.06M | -1.80M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 550.18M | 549.16M | 535.14M | 513.50M | 521.33M |
| Average Diluted Shares Outstanding | 550.18M | 549.16M | 535.14M | 513.50M | 521.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |